Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Relationship between Urinary Tract Infection Categorization and Pathogens’ Antimicrobial Susceptibilities

Yamamichi F.a · Shigemura K.a, b · Matsumoto M.a · Nakano Y.a · Tanaka K.a · Arakawa S.a · Fujisawa M.a

Author affiliations

aDivision of Urology, Department of Organs Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, and bDivision of Urology, Shinko Hospital, Kobe, Japan

Related Articles for ""

Urol Int 2012;88:198–208

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: August 24, 2011
Accepted: October 19, 2011
Published online: January 11, 2012
Issue release date: March 2012

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 7

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Background: Urinary tract infections (UTIs) can be hard to treat and treatment plans need to include accurate categorization such as uncomplicated or complicated UTI, or catheterized or uncatheterized UTI. We investigated the antibiotic susceptibilities of representative uropathogens in UTI categories. Methods: We isolated uropathogens and analyzed their antimicrobial susceptibilities according to UTI categorization such as: (1) urology outpatients, urology inpatients, or other department inpatients; (2) uncomplicated or complicated UTIs; (3) upper or lower UTIs, and (4) non-catheterized or catheterized UTIs. Results:Escherichia coli, Enterococcus faecalis, and Pseudomonas aeruginosa were representative uropathogens. Susceptibilities to levofloxacin (LVFX) in E. coli in urology outpatients (p = 0.0179), those to ceftadizime in E. coli in other department inpatients (p = 0.0327), and those to LVFX in E. faecalis in complicated UTI (p = 0.0137) significantly decreased in these 3 years compared with the previous 3 years. Susceptibilities of upper UTI to LVFX in E. coli were significantly lower in the recent 4 years compared to lower UTI (p = 0.0452) and those of catheterized UTI to LVFX in E. faecalis were significantly lower than in non-catheterized UTI (p = 0.0153). Conclusions: Data demonstrated different tendencies of uropathogens’ antibiotic susceptibilities according to UTI categorizations and they could be useful for planning UTI treatments.

© 2012 S. Karger AG, Basel


References

  1. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D: A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003;46:94–100.
  2. Al Benwan K, Al Sweih N, Rotimi VO: Etiology and antibiotic susceptibility of community- and hospital-acquired urinary tract infections in a general hospital in Kuwait. Med Princ Pract 2010;19:440–446.
    External Resources
  3. Bader MS, Hawboldt J, Brooks A: Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med 2010;122:7–15.
    External Resources
  4. Hooton T: The current management strategies for community-acquired urinary tract infection. Infec Dis Clin North Am 2003;17:303–332.
    External Resources
  5. Frank DN, Wilson SS, St Amand AL, Pace NR: Culture-independent microbiological analysis of Foley urinary catheter biofilms. PLoS One 2009;12:e7811.
    External Resources
  6. Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–332.
  7. Miragliotta G, Di Pierro MN, Miragliotta L, Mosca A: Antimicrobial resistance among for community-acquired urinary tract infections in an Italian community. J Chemother 2008;20:721–727.
  8. Neu HC: Urinary tract infections. Am J Med 1992;92:S63–S70.
  9. Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Shigeta S, Yamaguchi O, Ishibashi K, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Muratani T, Naito S, Egashira T, Konishi T, Kohno S, Hirakata Y, Kondo A, Matsuda J, Nakano M: Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibilities. Jpn J Antibiot 2006;59:217–315.
  10. Wagenlehner FM, Niemetz A, Dalhoff A, Naber KG: A spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994–2000. Int J Antimicrob Agents 2002;19:557–564.
  11. Turnidge J, Bell J, Biedenbach DJ, Jones RN: Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998–1999. Int J Antimicrob Agents 2002;20:10–17.
  12. Shigemura K, Arakawa S, Miura T, Nakano Y, Tanaka K, Fujisawa M: Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections. Jpn J Infect Dis 2008;61:226–228.
  13. Ejernæs K: Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan Med Bull 2011;58:B4187.
  14. De Francesco MA, Ravizzola G, Peroni L, Negrini R, Manca N: Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens. Med Sci Monit 2007;13:BR136–144.
  15. Wazait HD, Patel HR, Veer V, Kelsey M, Van Der Meulen JH, Miller RA, Emberton M: Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996–2001). BJU Int 2003;91:806–809.
  16. Akram M, Shahid M, Khan AU: Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbol Antimicrob 2007;6:4.
  17. Behrooozi A, Rahbar M, Yousefi JV: Frequency of extended spectrum β-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumonia isolated from urine in an Iranian 1,000-bed tertiary care hospital. Afr J Micrbiol Res 2010;5:881–884.
  18. Hachem RY, Chemaly RF, Ahmar CA, Jiang Y, Boktour MR, Rjaili GA, Bodey GP, Raad II: Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother 2007;51:1905–1911.
  19. Conceição N, de Oliveira Cda C, da Silva PR, Avila BG, de Oliveira AG: Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study. Rev Soc Bras Med Trop 2011;44:177–181.
    External Resources
  20. Idress M, Mussarat U, Badshah Y, Qamar R, Bokhari H: Virulence factors profile of drug-resistant Escherichia coli isolates from urinary tract infections in Punjab, Pakistan. Eur J Clin Microbiol Infect Dis 2010;29:1533–1537.
  21. Maki DG, Tambyah PA: Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001;7:342–347.
  22. Bosch FJ, van Vuuren C, Joubert G: Antimicrobial resistance patterns in outpatient urinary tract infections – the constant need to revise prescribing habits. S Afr Med J 2011;101:328–331.
    External Resources
  23. Shigemura K, Tanaka K, Adachi M, Yamashita M, Arakawa S, Fujisawa M: Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections. J Infect Chemother 2011;17:646–651.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: August 24, 2011
Accepted: October 19, 2011
Published online: January 11, 2012
Issue release date: March 2012

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 7

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.